BRIEF-Sino Biopharmaceutical Says Azacitidine Obtained Approval For Drug Registration

Oct 10 (Reuters) - Sino Biopharmaceutical Ltd:

* AZACITIDINE FOR INJECTION OBTAINED APPROVAL FOR DRUG REGISTRATION FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC

* AZACITIDINE IS INDICATED FOR TREATMENT OF ALL SUBTYPES OF MYELODYSPLASTIC SYNDROME AND HAS BEEN GIVEN ORPHAN-DRUG STATUS Source text for Eikon: Further company coverage: